Background: Overweight (OW) and obesity (OB) are major public health challenges associated with metabolic disorders, chronic diseases, and rising healthcare costs. Low-carbohydrate diets (LCDs) have emerged as cost-effective strategies for prevention and treatment. Objective: The objective of the study is to evaluate the effects of an LCD (≤130 g/day) on anthropometric, metabolic, hepatic, and renal parameters in OW and obese adults over 12 months. Methods: This open-label, non-randomized, self-controlled clinical trial included 34 adults with body mass index (BMI) ≥ 25 kg/m2 who received individualized nutritional counseling and followed an LCD for up to 12 months. Clinical and laboratory parameters were assessed at baseline and during follow-up (3–6 months and 7–12 months). Statistical analyses included generalized estimating equations and non-parametric tests with Bonferroni correction. Results: Participants achieved a mean weight loss of 10%, with reductions in BMI (−2.9 kg/m2), waist circumference (−5.4 cm), and body fat percentage. Glycated hemoglobin decreased at 7–12 months (p<0.05), while insulin levels and insulin resistance declined at 3–6 months (p=0.0497 and p=0.037). Fasting glucose remained stable. Low-density lipoprotein cholesterol increased modestly at 7–12 months (p=0.035), whereas other lipid parameters showed no significant changes. Gamma-glutamyl transferase levels decreased (p=0.0341), with no adverse effects on renal or hepatic markers. Conclusion: An LCD was associated with improvements in glycemic control, body composition, insulin sensitivity, and liver enzymes without compromising renal function or lipid profiles, supporting its role in OB management and cardiometabolic risk reduction in primary care.